The Selection of DNA Aptamers for the Prevention of Alpha-Synuclein Aggregation as a Therapeutic Tool in Parkinson's Disease

doi 10.22215/etd/2017-12144
Full Text
Abstract

Available in full text

Date

Unknown

Authors
Publisher

Carleton University

Related search

Aptamers as a Promising Therapeutic Tool for Cancer Immunotherapy

2017English

Alpha-Synuclein Repeat Variants and Survival in Parkinson's Disease

Movement Disorders
Neurology
2014English

LRRK2 Is a Component of Granular Alpha-Synuclein Pathology in the Brainstem of Parkinson's Disease

Neuropathology and Applied Neurobiology
Forensic MedicinePathologyNeurologyHistologyPhysiology
2008English

Alpha-Synuclein Mutations Impair Axonal Regeneration in Models of Parkinson's Disease

Frontiers in Aging Neuroscience
AgingCognitive Neuroscience
2014English

Detection of Alpha-Synuclein Conformational Variants From Gastro-Intestinal Biopsy Tissue as a Potential Biomarker for Parkinson's Disease

Neuropathology and Applied Neurobiology
Forensic MedicinePathologyNeurologyHistologyPhysiology
2018English

Selection of DNA Aptamers for Mycotoxins

English

A Systematic Review and Meta-Analysis of Alpha Synuclein Auto-Antibodies in Parkinson's Disease

Frontiers in Neurology
Neurology
2018English

Temperature-Dependent Structural Changes of Parkinson's Alpha-Synuclein Reveal the Role of Pre-Existing Oligomers in Alpha-Synuclein Fibrillization

PLoS ONE
Multidisciplinary
2013English

Understanding and Preventing Aggregation in Alpha-Synuclein

Biophysical Journal
Biophysics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy